{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:08:38Z","timestamp":1774494518463,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T00:00:00Z","timestamp":1474329600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Health Labor Science Research Grants from Research on Measures for Intractable Diseases, the Intractable Hepato-Biliary Diseases Study Group in Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s12072-016-9767-9","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T12:28:12Z","timestamp":1474374492000},"page":"909-915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Autoimmune liver diseases in the Asia\u2013Pacific region: Proceedings of APASL symposium on AIH and PBC 2016"],"prefix":"10.1007","volume":"10","author":[{"given":"Atsushi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yokosuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Weltman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak N.","family":"Amarapurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaigham","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana A.","family":"Payawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cumali","family":"Efe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersan","family":"Ozaslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Mitchell-Thain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Zeniya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Hyub","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Vierling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"key":"9767_CR1","doi-asserted-by":"crossref","unstructured":"Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. Lancet 2013;382: 1433\u20131444","DOI":"10.1016\/S0140-6736(12)62163-1"},{"key":"9767_CR2","doi-asserted-by":"crossref","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51: 2193\u20132213","DOI":"10.1002\/hep.23584"},{"key":"9767_CR3","doi-asserted-by":"crossref","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31: 929\u2013938","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"9767_CR4","doi-asserted-by":"crossref","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48: 169\u2013176","DOI":"10.1002\/hep.22322"},{"key":"9767_CR5","doi-asserted-by":"crossref","unstructured":"Kim BH, Kim YJ, Jeong SH, Tak WY, Ahn SH, Lee YJ, et al. Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study. J Gastroenterol Hepatol 2013;28: 128\u2013134","DOI":"10.1111\/j.1440-1746.2012.07292.x"},{"key":"9767_CR6","doi-asserted-by":"crossref","unstructured":"Abe M, Mashiba T, Zeniya M, Yamamoto K, Onji M, Tsubouchi H, et al. Present status of autoimmune hepatitis in Japan: a nationwide survey. J Gastroenterol 2011;46: 1136\u20131141","DOI":"10.1007\/s00535-011-0421-y"},{"key":"9767_CR7","doi-asserted-by":"crossref","unstructured":"Qiu D, Wang Q, Wang H, Xie Q, Zang G, Jiang H, et al. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol 2011;54: 340\u2013247","DOI":"10.1016\/j.jhep.2010.06.032"},{"key":"9767_CR8","doi-asserted-by":"crossref","unstructured":"Amarapurkar D, Dharod M, Amarapurkar A. Autoimmune hepatitis in India: single tertiary referral centre experience. Troop Gastroenterol 2015;36: 36\u201345","DOI":"10.7869\/tg.243"},{"key":"9767_CR9","doi-asserted-by":"crossref","unstructured":"Hassan N, Siddiqui A, Abbas Z, Hassan S, Soomro G, Mubarak M, et al. Clinical Profile and HLA Typing of Autoimmune Hepatitis From Pakistan. Hepat Mon 2013;13: e13598","DOI":"10.5812\/hepatmon.13598"},{"key":"9767_CR10","doi-asserted-by":"crossref","unstructured":"Koay L, Lin C, Tsai S, Lee C, Lin C, Sheu M, et al. Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group. Dig Dis Sci 2006;51: 1978\u20131984","DOI":"10.1007\/s10620-005-9068-y"},{"key":"9767_CR11","doi-asserted-by":"crossref","unstructured":"Yeh S, Ni Y, Jeng Y, Chen H, Wu J, Chang M. Emerging importance of autoimmune hepatitis in children in Taiwan, an endemic area for viral hepatitis. Pediatr Neonatol 2009;50: 65\u201369","DOI":"10.1016\/S1875-9572(09)60035-8"},{"key":"9767_CR12","unstructured":"Huang H, Huang Y, Wu J, Tsay S, Huo T, Wang Y, et al. Characteristics of autoimmune hepatitis in Taiwan: the 11\u00a0years\u2019 experiences of a medical center. Zhonghua Yi Xue Za Zhi (Taipei) 2002;65: 563\u2013569"},{"key":"9767_CR13","unstructured":"Huo T, Wu J, Huang Y, Lai C, Tsay S, Lee S. Autoimmune hepatitis in an area endemic for hepatitis B virus infection: a report of three cases. Zhonghua Yi Xue Za Zhi (Taipei) 1996;57: 360\u2013364"},{"key":"9767_CR14","unstructured":"Huang H, Wu J, Huang Y, Teh-Ia H, Lo J, Li C, et al. Genetic distinctions and clinical characteristics of type 1 autoimmune hepatitis in Taiwan. Hepatogastroenterology 2008;55"},{"key":"9767_CR15","doi-asserted-by":"crossref","unstructured":"Haider AS, Kaye G, Thomson A. Autoimmune hepatitis in a demographically isolated area of Australia. Int Med J 2010;40: 281\u2013285","DOI":"10.1111\/j.1445-5994.2009.02041.x"},{"key":"9767_CR16","doi-asserted-by":"crossref","unstructured":"Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease. BMC Gastroenterol 2005;5: 27","DOI":"10.1186\/1471-230X-5-27"},{"key":"9767_CR17","unstructured":"Gohar S, Desai D, Joshi A, Bhaduri A, Deshpande R, Balkrishna C, et al. Autoimmune hepatitis: a study of 50 patients. Indian J Gastroenterol 2003;22: 140\u2013142"},{"key":"9767_CR18","doi-asserted-by":"crossref","unstructured":"Amarapurkar D, Patel N. Spectrum of autoimmune liver diseases in western India. J Gastroenterol Hepatol 2007;22: 2112\u20132117","DOI":"10.1111\/j.1440-1746.2007.05048.x"},{"key":"9767_CR19","doi-asserted-by":"crossref","unstructured":"Sood S, Gow PJ, Christie JM, Angus PW. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology 2004;127: 470\u2013475","DOI":"10.1053\/j.gastro.2004.04.064"},{"key":"9767_CR20","doi-asserted-by":"crossref","unstructured":"Liu H, Liu Y, Wang L, Xu D, Lin B, Zhong R, et al. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterol 2010;10: 100","DOI":"10.1186\/1471-230X-10-100"},{"key":"9767_CR21","doi-asserted-by":"crossref","unstructured":"Sakauchi F, Mori M, Zeniya M, Toda G. A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol 2005;15: 24\u201328","DOI":"10.2188\/jea.15.24"},{"key":"9767_CR22","doi-asserted-by":"crossref","unstructured":"Kim KA, Ki M, Choi HY, Kim BH, Jang ES, Jeong SH. Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther 2016;43: 154\u2013162","DOI":"10.1111\/apt.13448"},{"key":"9767_CR23","doi-asserted-by":"crossref","unstructured":"he Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health LaWoJ. Guidelines for the management of primary biliary cirrhosis. Hepatol Res 2014;44 Suppl S1: 71\u201390","DOI":"10.1111\/hepr.12270"},{"key":"9767_CR24","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51: 237\u2013267","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"9767_CR25","doi-asserted-by":"crossref","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ, et al. Primary biliary cirrhosis. Hepatology 2009;50: 291\u2013308","DOI":"10.1002\/hep.22906"},{"key":"9767_CR26","doi-asserted-by":"crossref","unstructured":"Chan CY, Lee SD, Huang YS, Wu JC, Tsai YT, Tsay SH, et al. Primary biliary cirrhosis in Taiwan. J Gastroenterol Hepatol 1990;5: 560-565","DOI":"10.1111\/j.1440-1746.1990.tb01441.x"},{"key":"9767_CR27","doi-asserted-by":"crossref","unstructured":"Hosonuma K, Sato K, Yamazaki Y, Yanagisawa M, Hashizume H, Horiguchi N, et al. A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia. Am J Gastroenterol 2015;110: 423\u2013431","DOI":"10.1038\/ajg.2015.20"},{"key":"9767_CR28","doi-asserted-by":"crossref","unstructured":"Chen CL, Yang JY, Lin SF, Sun CA, Bai CH, You SL, et al. Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan. J Hepatol 2015;63: 354\u2013363","DOI":"10.1016\/j.jhep.2015.03.013"},{"key":"9767_CR29","doi-asserted-by":"crossref","unstructured":"Chien RN, Sheen IS, Liaw YF. Low prevalences of HBV and HCV infection in patients with primary biliary cirrhosis in Taiwan: a case control study. J Gastroenterol Hepatol 1993;8: 574\u2013576","DOI":"10.1111\/j.1440-1746.1993.tb01655.x"},{"key":"9767_CR30","doi-asserted-by":"crossref","unstructured":"Sui M, Wu R, Hu X, Zhang H, Jiang J, Yang Y, et al. Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population. J Viral Hepat 2014;21: 925\u2013929","DOI":"10.1111\/jvh.12302"},{"key":"9767_CR31","doi-asserted-by":"crossref","unstructured":"Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011;54: 374\u2013385","DOI":"10.1016\/j.jhep.2010.09.002"},{"key":"9767_CR32","doi-asserted-by":"crossref","unstructured":"Bonder A, Retana A, Winston DM, Leung J, Kaplan MM. Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 2011;9: 609\u2013612","DOI":"10.1016\/j.cgh.2011.03.019"},{"key":"9767_CR33","doi-asserted-by":"crossref","unstructured":"Neuhauser M, Bjornsson E, Treeprasertsuk S, Enders F, Silveira M, Talwalkar J, et al. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol 2010;105: 345\u2013353","DOI":"10.1038\/ajg.2009.616"},{"key":"9767_CR34","doi-asserted-by":"crossref","unstructured":"Yang F, Wang Q, Wang Z, Miao Q, Xiao X, Tang R, et al. The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis. Clin Rev Allergy Immunol 2016;50: 114\u2013123","DOI":"10.1007\/s12016-015-8516-5"},{"key":"9767_CR35","doi-asserted-by":"crossref","unstructured":"Chazouilleres O, Wendum D, Serfety L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998;28: 296\u2013301","DOI":"10.1002\/hep.510280203"},{"key":"9767_CR36","doi-asserted-by":"crossref","unstructured":"Efe C, Ozaslan E, Heurgue-Berlot A, Kav T, Masi C, Purnak T, et al. Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol 2014;26: 532\u2013537","DOI":"10.1097\/MEG.0000000000000075"},{"key":"9767_CR37","doi-asserted-by":"crossref","unstructured":"Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology 2002;35: 409\u2013413","DOI":"10.1053\/jhep.2002.30902"},{"key":"9767_CR38","doi-asserted-by":"crossref","unstructured":"Tanaka A, Harada K, Ebinuma H, Komori A, Yokokawa J, Yoshizawa K, et al. Primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan. Hepatol Res 2011;41: 877\u2013886","DOI":"10.1111\/j.1872-034X.2011.00844.x"},{"key":"9767_CR39","doi-asserted-by":"crossref","unstructured":"Ozaslan E, Efe C, Heurgue-Berlot A, Kav T, Masi C, Purnak T, et al. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2014;12: 863\u2013869","DOI":"10.1016\/j.cgh.2013.09.021"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-016-9767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-016-9767-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-016-9767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T23:14:33Z","timestamp":1498346073000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-016-9767-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["9767"],"URL":"https:\/\/doi.org\/10.1007\/s12072-016-9767-9","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]}}}